Jubilant Life Sciences’ arm to launch unsecured high yield bonds

23 Sep 2016 Evaluate

Jubilant Life Sciences’ material wholly-owned subsidiary ‘Jubilant Pharma’ (JPL), has received an approval to launch a benchmark offering of unsecured high yield bonds outside India, under Regulation S of the US Securities Act. The bonds are proposed to be listed on the Singapore Exchange Securities Trading. The board of directors at its meeting held on September 23, 2016 has approved for the same.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.


Jubilant Pharmova Share Price

954.65 -13.60 (-1.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×